Mycotopia Therapies, PSLY.com, and Ei.Ventures mutually terminate merger agreement

AIBOTICS, INC.

Parties agreed to terminate the Agreement and Plan of Merger dated May 17, 2022 on February 16, 2023.
PSLY.com is withdrawing its Form S-4 Registration Statement and discontinuing its Nasdaq listing application.
CEO David Nikzad cited it was not the right time for the business combination or Nasdaq listing.
Mycotopia CEO Ben Kaplan noted overall market conditions were not favorable for creating optimal shareholder value.

item 1.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

AIBOTICS, INC. terminated Agreement and Plan of Merger with PSLY.com (effective 2023-02-16).

Action: termination
Agreement: merger
Counterparty: PSLY.com
Effective: 2023-02-16

Exact text from the filing

On May 18, 2022, Mycotopia Therapies Inc. (the “Company”) entered into an Agreement and Plan of Merger (the “Agreement”) whereby the Company was to merge with a wholly owned subsidiary of PSLY.com. Simultaneously E.iVentures, Inc. (“E.i”) was to merge with a separate wholly owned subsidiary of PSLY.com. On February 16, 2023, the parties to the Agreement mutually agreed to terminate the Agreement and release each other.

View on SEC.gov

Browse all material agreements →

AIBOTICS, INC. filing history →

Source: SEC EDGAR

accession 0001096906-23-000428

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.